logo
#

Latest news with #Duratec

ASX Penny Stocks To Consider In May 2025
ASX Penny Stocks To Consider In May 2025

Yahoo

time20-05-2025

  • Business
  • Yahoo

ASX Penny Stocks To Consider In May 2025

The Australian market recently saw a positive shift, with the ASX200 closing up 0.58% at 8,343 points following an interest rate cut by the Reserve Bank of Australia. This environment highlights opportunities for investors to explore smaller or newer companies that might not be on everyone's radar yet. Penny stocks, while an older term, still represent a valuable segment of the market where strong financial health and growth potential can lead to rewarding investments. Name Share Price Market Cap Financial Health Rating Lindsay Australia (ASX:LAU) A$0.71 A$225.19M ★★★★☆☆ CTI Logistics (ASX:CLX) A$1.83 A$147.4M ★★★★☆☆ Accent Group (ASX:AX1) A$1.93 A$1.16B ★★★★☆☆ EZZ Life Science Holdings (ASX:EZZ) A$1.74 A$82.08M ★★★★★★ IVE Group (ASX:IGL) A$2.57 A$396.25M ★★★★★☆ GTN (ASX:GTN) A$0.60 A$114.64M ★★★★★★ West African Resources (ASX:WAF) A$2.33 A$2.66B ★★★★★★ Bisalloy Steel Group (ASX:BIS) A$3.46 A$164.18M ★★★★★★ Regal Partners (ASX:RPL) A$2.16 A$726.11M ★★★★★★ Navigator Global Investments (ASX:NGI) A$1.795 A$879.69M ★★★★★☆ Click here to see the full list of 997 stocks from our ASX Penny Stocks screener. Let's explore several standout options from the results in the screener. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Duratec Limited, with a market cap of A$396.25 million, provides assessment, protection, remediation, and refurbishment services for steel and concrete infrastructure assets in Australia. Operations: Duratec's revenue is primarily derived from its Defence segment at A$193.48 million, followed by Mining & Industrial at A$144.05 million, Buildings & Facades at A$113.64 million, and Energy at A$62.54 million. Market Cap: A$396.25M Duratec Limited, with a market cap of A$396.25 million, shows mixed signals for investors in the penny stock category. The company is trading at 23.4% below its estimated fair value and analysts agree on a potential price increase of 22.7%. Despite negative earnings growth last year, Duratec's profits have grown significantly over the past five years and are forecast to grow by 15.46% annually. The management team is experienced with an average tenure of 2.3 years, and the board has substantial experience as well, averaging 14.8 years in tenure per member. Take a closer look at Duratec's potential here in our financial health report. Examine Duratec's earnings growth report to understand how analysts expect it to perform. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Pantoro Gold Limited, along with its subsidiaries, is involved in gold mining, processing, and exploration activities in Western Australia and has a market cap of A$1.23 billion. Operations: Pantoro Gold generates revenue primarily from its Norseman Gold Project, amounting to A$289.11 million. Market Cap: A$1.23B Pantoro Gold Limited, with a market cap of A$1.23 billion, presents a complex picture for investors interested in penny stocks. The company is currently unprofitable but has sufficient cash runway for over three years, even if its positive free cash flow diminishes by 23.6% annually. While trading at 41.9% below its estimated fair value and having more cash than total debt, Pantoro's earnings are forecast to grow significantly by 57.28% per year despite increased losses over the past five years at a rate of 32%. Recent drilling results from the Norseman project show promising continuity and potential resource upgrades, supporting future growth prospects. Click here and access our complete financial health analysis report to understand the dynamics of Pantoro Gold. Gain insights into Pantoro Gold's future direction by reviewing our growth report. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Service Stream Limited is an Australian company that designs, constructs, operates, and maintains infrastructure networks in the telecommunications, utilities, and transport sectors with a market cap of A$1.17 billion. Operations: The company's revenue is primarily derived from three segments: Telecommunications (A$1.23 billion), Utilities (A$1.02 billion), and Transport (A$123.34 million). Market Cap: A$1.17B Service Stream Limited, with a market cap of A$1.17 billion, offers an intriguing profile for penny stock investors. The company is debt-free and shows robust short-term financial health, with assets exceeding both short and long-term liabilities. Its earnings growth of 124.7% over the past year surpasses industry averages, though its Return on Equity remains low at 10.6%. Despite trading at 45.7% below estimated fair value and experiencing significant insider selling recently, it maintains high-quality earnings with improved profit margins from last year. Recent board changes bring strategic expertise but highlight inexperience within the board's average tenure. Navigate through the intricacies of Service Stream with our comprehensive balance sheet health report here. Understand Service Stream's earnings outlook by examining our growth report. Discover the full array of 997 ASX Penny Stocks right here. Contemplating Other Strategies? Rare earth metals are an input to most high-tech devices, military and defence systems and electric vehicles. The global race is on to secure supply of these critical minerals. Beat the pack to uncover the 23 best rare earth metal stocks of the very few that mine this essential strategic resource. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ASX:DUR ASX:PNR and ASX:SSM. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@

ASX Growth Companies With Strong Insider Ownership May 2025
ASX Growth Companies With Strong Insider Ownership May 2025

Yahoo

time20-05-2025

  • Business
  • Yahoo

ASX Growth Companies With Strong Insider Ownership May 2025

The Australian market has shown resilience, with the ASX200 closing up 0.58% at 8,343 points after a rate cut by the RBA, highlighting strong performances in the IT and Real Estate sectors. In this environment of shifting interest rates and sectoral growth, companies with high insider ownership often signal confidence from those who know the business best, making them attractive considerations for investors seeking growth opportunities on the ASX. Name Insider Ownership Earnings Growth Alfabs Australia (ASX:AAL) 10.8% 41.3% Cyclopharm (ASX:CYC) 11.3% 97.8% Fenix Resources (ASX:FEX) 21.1% 53.4% Brightstar Resources (ASX:BTR) 11.6% 98.8% Newfield Resources (ASX:NWF) 31.5% 72.1% AVA Risk Group (ASX:AVA) 15.4% 108.2% Titomic (ASX:TTT) 11.2% 77.2% Plenti Group (ASX:PLT) 12.7% 89.6% Image Resources (ASX:IMA) 20.6% 79.9% BETR Entertainment (ASX:BBT) 30.4% 121.8% Click here to see the full list of 98 stocks from our Fast Growing ASX Companies With High Insider Ownership screener. Let's take a closer look at a couple of our picks from the screened companies. Simply Wall St Growth Rating: ★★★★☆☆ Overview: Duratec Limited, listed on the ASX under the ticker DUR, specializes in the assessment, protection, remediation, and refurbishment of steel and concrete infrastructure across Australia with a market capitalization of A$396.25 million. Operations: The company's revenue segments include Energy (A$62.54 million), Defence (A$193.48 million), Buildings & Facades (A$113.64 million), and Mining & Industrial (A$144.05 million). Insider Ownership: 31.2% Return On Equity Forecast: 35% (2027 estimate) Duratec shows potential as a growth company with high insider ownership in Australia. Its earnings are forecast to grow at 15.46% annually, outpacing the Australian market's average of 11.7%. Despite trading at A$23.4% below its estimated fair value, the stock is expected to rise by 22.7%, according to analysts. Although revenue growth is moderate at 9.4% per year, it's still above the market average of 5.5%. Take a closer look at Duratec's potential here in our earnings growth report. According our valuation report, there's an indication that Duratec's share price might be on the cheaper side. Simply Wall St Growth Rating: ★★★★★☆ Overview: PWR Holdings Limited specializes in the design, production, and sale of cooling products and solutions across various international markets, with a market cap of A$703.95 million. Operations: The company's revenue segments consist of PWR C&R at A$46.48 million and PWR Performance Products at A$109.04 million. Insider Ownership: 13.3% Return On Equity Forecast: 26% (2027 estimate) PWR Holdings demonstrates potential for growth, with insiders significantly increasing their holdings over the last three months. Despite a recent dip in net income to A$4.08 million, forecasts suggest robust annual earnings growth of 24.7%, surpassing the Australian market average. Revenue is expected to grow at 13.5% annually, and the stock trades at 20.5% below its estimated fair value, indicating possible undervaluation amidst high insider confidence and anticipated financial improvement. Delve into the full analysis future growth report here for a deeper understanding of PWR Holdings. The valuation report we've compiled suggests that PWR Holdings' current price could be inflated. Simply Wall St Growth Rating: ★★★★★☆ Overview: Telix Pharmaceuticals Limited is a commercial-stage biopharmaceutical company that develops and commercializes therapeutic and diagnostic radiopharmaceuticals for cancer and rare diseases across Australia, Belgium, Japan, Switzerland, and the United States with a market cap of A$8.57 billion. Operations: The company's revenue is derived from three main segments: Therapeutics (A$9.35 million), Precision Medicine (A$771.11 million), and Manufacturing Solutions (A$2.75 million). Insider Ownership: 14.9% Return On Equity Forecast: 28% (2027 estimate) Telix Pharmaceuticals, a growth-oriented company in the radiopharmaceutical sector, has seen substantial insider selling recently. Despite this, it projects strong financial performance with earnings expected to grow at 33.2% annually and revenue at 19.5%, both outpacing the Australian market averages. The recent marketing authorizations for its prostate cancer imaging agent Illuccix® in multiple countries bolster its international presence and potential revenue streams, while trading significantly below estimated fair value suggests possible undervaluation. Click here and access our complete growth analysis report to understand the dynamics of Telix Pharmaceuticals. In light of our recent valuation report, it seems possible that Telix Pharmaceuticals is trading behind its estimated value. Gain an insight into the universe of 98 Fast Growing ASX Companies With High Insider Ownership by clicking here. Looking For Alternative Opportunities? Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years. Companies discussed in this article include ASX:DUR ASX:PWH and ASX:TLX. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio

ASX Stocks Estimated Below Fair Value To Watch In May 2025
ASX Stocks Estimated Below Fair Value To Watch In May 2025

Yahoo

time20-05-2025

  • Business
  • Yahoo

ASX Stocks Estimated Below Fair Value To Watch In May 2025

The Australian market has recently experienced a boost, with the ASX200 closing up 0.58% following a rate cut by the Reserve Bank of Australia, highlighting strength in sectors such as IT and Real Estate. In this environment, identifying undervalued stocks becomes crucial for investors seeking opportunities to capitalize on potential gains, especially when certain sectors are showing resilience and growth prospects amidst broader economic shifts. Name Current Price Fair Value (Est) Discount (Est) Smart Parking (ASX:SPZ) A$0.975 A$1.76 44.6% Lynas Rare Earths (ASX:LYC) A$7.62 A$13.43 43.3% Austal (ASX:ASB) A$5.02 A$9.20 45.4% Charter Hall Group (ASX:CHC) A$17.98 A$34.25 47.5% SciDev (ASX:SDV) A$0.36 A$0.68 47.1% Polymetals Resources (ASX:POL) A$0.79 A$1.52 48% Genesis Minerals (ASX:GMD) A$3.89 A$6.75 42.4% Pantoro Gold (ASX:PNR) A$3.15 A$5.42 41.9% PointsBet Holdings (ASX:PBH) A$1.095 A$2.08 47.3% Superloop (ASX:SLC) A$2.57 A$4.52 43.1% Click here to see the full list of 39 stocks from our Undervalued ASX Stocks Based On Cash Flows screener. Let's explore several standout options from the results in the screener. Overview: Duratec Limited, with a market cap of A$396.25 million, provides assessment, protection, remediation, and refurbishment services for steel and concrete infrastructure assets in Australia. Operations: The company's revenue segments are comprised of Energy (A$62.54 million), Defence (A$193.48 million), Buildings & Facades (A$113.64 million), and Mining & Industrial (A$144.05 million). Estimated Discount To Fair Value: 23.4% Duratec is trading at A$1.57, significantly below its estimated fair value of A$2.05, indicating potential undervaluation based on cash flows. Analysts expect the stock price to rise by 22.7%, supported by forecasted earnings growth of 15.46% annually, outpacing the Australian market's 11.7%. Revenue growth is projected at 9.4% per year, exceeding the market average of 5.5%. Duratec's return on equity is anticipated to be high in three years at 34.8%. Insights from our recent growth report point to a promising forecast for Duratec's business outlook. Take a closer look at Duratec's balance sheet health here in our report. Overview: Mader Group Limited is a contracting company offering specialist technical services in the mining, energy, and industrial sectors both in Australia and internationally, with a market cap of A$1.24 billion. Operations: The company's revenue primarily comes from its Staffing & Outsourcing Services segment, which generated A$811.54 million. Estimated Discount To Fair Value: 23.8% Mader Group is trading at A$6.15, below its estimated fair value of A$8.07, highlighting potential undervaluation based on cash flows. Earnings are projected to grow 13.48% annually, surpassing the Australian market's 11.7%. Despite significant insider selling recently, Mader reaffirmed its fiscal year 2025 guidance with expected revenue of at least A$870 million and NPAT of at least A$57 million, supporting a robust financial outlook amidst strong past earnings growth. The analysis detailed in our Mader Group growth report hints at robust future financial performance. Click here and access our complete balance sheet health report to understand the dynamics of Mader Group. Overview: PolyNovo Limited designs, manufactures, and sells biodegradable medical devices in the United States, Australia, New Zealand, and internationally with a market cap of A$949.91 million. Operations: The company's revenue primarily comes from the development, manufacturing, and commercialization of the NovoSorb technology, amounting to A$115.58 million. Estimated Discount To Fair Value: 28.0% PolyNovo, trading at A$1.38, is below its estimated fair value of A$1.91, suggesting undervaluation based on cash flows. The company's earnings have grown significantly by 270.2% over the past year and are forecast to increase by 39.6% annually, outpacing the Australian market's growth rate of 11.7%. Recent unaudited results show strong revenue growth with A$91.6 million reported for the year to date as of March 31, 2025. Our expertly prepared growth report on PolyNovo implies its future financial outlook may be stronger than recent results. Click to explore a detailed breakdown of our findings in PolyNovo's balance sheet health report. Discover the full array of 39 Undervalued ASX Stocks Based On Cash Flows right here. Have you diversified into these companies? Leverage the power of Simply Wall St's portfolio to keep a close eye on market movements affecting your investments. Invest smarter with the free Simply Wall St app providing detailed insights into every stock market around the globe. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ASX:DUR ASX:MAD and ASX:PNV. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Duratec First Half 2025 Earnings: EPS Beats Expectations, Revenues Lag
Duratec First Half 2025 Earnings: EPS Beats Expectations, Revenues Lag

Yahoo

time25-02-2025

  • Business
  • Yahoo

Duratec First Half 2025 Earnings: EPS Beats Expectations, Revenues Lag

Revenue: AU$287.3m (down 1.9% from 1H 2024). Net income: AU$13.0m (up 6.1% from 1H 2024). Profit margin: 4.5% (up from 4.2% in 1H 2024). The increase in margin was driven by lower expenses. EPS: AU$0.052 (up from AU$0.05 in 1H 2024). All figures shown in the chart above are for the trailing 12 month (TTM) period Revenue missed analyst estimates by 2.0%. Earnings per share (EPS) exceeded analyst estimates by 17%. Looking ahead, revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 6.5% growth forecast for the Construction industry in Australia. Performance of the Australian Construction industry. The company's shares are down 2.3% from a week ago. Just as investors must consider earnings, it is also important to take into account the strength of a company's balance sheet. We have a graphic representation of Duratec's balance sheet and an in-depth analysis of the company's financial position. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store